These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 34655006)

  • 1. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
    Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
    Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
    Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
    Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells.
    Alves SR; Colquhoun A; Wu XY; de Oliveira Silva D
    J Inorg Biochem; 2020 Apr; 205():110984. PubMed ID: 31927403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.
    Zhong Y; Wang C; Cheng R; Cheng L; Meng F; Liu Z; Zhong Z
    J Control Release; 2014 Dec; 195():63-71. PubMed ID: 25108151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
    Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
    Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme.
    Ortega-Berlanga B; Gonzalez C; Navarro-Tovar G
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):8. PubMed ID: 33772646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
    Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
    J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
    Mo J; He L; Ma B; Chen T
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
    Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
    J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
    Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
    J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
    Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
    Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
    Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages.
    Zhang T; Lip H; He C; Cai P; Wang Z; Henderson JT; Rauth AM; Wu XY
    Adv Healthc Mater; 2019 Sep; 8(18):e1900543. PubMed ID: 31348614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
    Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
    ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide.
    Han M; Xing H; Chen L; Cui M; Zhang Y; Qi L; Jin M; Yang Y; Gao C; Gao Z; Xing X; Huang W
    J Drug Target; 2021 Nov; 29(9):1016-1028. PubMed ID: 33825602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood-Brain Barrier.
    Kostka K; Sokolova V; El-Taibany A; Kruse B; Porada D; Wolff N; Prymak O; Seeds MC; Epple M; Atala AJ
    Molecules; 2024 May; 29(11):. PubMed ID: 38893345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.